Artiva Biotherapeutics, Inc. (ARTV) Insider Trading -- Recent Executive & Director Transactions

15 insiders reported 88 Form 4 transactions for Artiva Biotherapeutics, Inc. (ARTV) over the past 18 months (most recent 2026-06-16). Recent activity: RA Capital Nexus Fund, L.P. (Director) Buy 124,893 shares, RA Capital Healthcare Fund LP (Director) Buy 124,893 shares, RA Capital Nexus Fund, L.P. (Director) Buy 391,019 shares, Shah Rajeev M. (Director) Buy 391,019 shares, Kolchinsky Peter (Director) Buy 391,019 shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-06-16RA Capital Nexus Fund, L.P.DirectorBuy124,893$1.1M
2026-06-16RA Capital Healthcare Fund LPDirectorBuy124,893$1.1M
2026-06-16RA Capital Nexus Fund, L.P.DirectorBuy391,019$3.4M
2026-06-16Shah Rajeev M.DirectorBuy391,019$3.4M
2026-06-16Kolchinsky PeterDirectorBuy391,019$3.4M
2026-06-16RA CAPITAL MANAGEMENT, L.P.DirectorBuy391,019$3.4M
2026-06-16RA Capital Nexus Fund III, L.P.DirectorBuy15,414$138,572
2026-06-16RA Capital Nexus Fund III, L.P.DirectorBuy391,019$3.4M
2026-06-16Kolchinsky PeterDirectorBuy15,414$138,572
2026-06-16RA CAPITAL MANAGEMENT, L.P.DirectorBuy15,414$138,572
2026-06-16RA Capital Healthcare Fund LPDirectorBuy15,414$138,572
2026-06-16Shah Rajeev M.DirectorBuy15,414$138,572
2026-06-16RA Capital Nexus Fund III, L.P.DirectorBuy124,893$1.1M
2026-06-16RA Capital Healthcare Fund LPDirectorBuy391,019$3.4M
2026-06-16Shah Rajeev M.DirectorBuy124,893$1.1M
2026-06-16Kolchinsky PeterDirectorBuy124,893$1.1M
2026-06-16RA CAPITAL MANAGEMENT, L.P.DirectorBuy124,893$1.1M
2026-06-16RA Capital Nexus Fund, L.P.DirectorBuy15,414$138,572
2026-06-11RA Capital Nexus Fund III, L.P.DirectorBuy479,039$3.3M
2026-06-11RA Capital Nexus Fund III, L.P.DirectorBuy103$721
2026-06-11RA Capital Healthcare Fund LPDirectorBuy479,039$3.3M
2026-06-11Kolchinsky PeterDirectorBuy479,039$3.3M
2026-06-11RA CAPITAL MANAGEMENT, L.P.DirectorBuy479,039$3.3M
2026-06-11Shah Rajeev M.DirectorBuy479,039$3.3M
2026-06-11RA Capital Nexus Fund, L.P.DirectorBuy479,039$3.3M

Source: SEC Form 4 filings · as of 2026-06-16